QUILONUM RETARD

Quilonum Retard Adverse Events Reported to the FDA Over Time

How are Quilonum Retard adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Quilonum Retard, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Quilonum Retard is flagged as the suspect drug causing the adverse event.

Most Common Quilonum Retard Adverse Events Reported to the FDA

What are the most common Quilonum Retard adverse events reported to the FDA?

Suicide Attempt	65 (8.07%)
Intentional Overdose	37 (4.6%)
Somnolence	26 (3.23%)
Vomiting	25 (3.11%)
Nausea	22 (2.73%)
Diarrhoea	21 (2.61%)
Renal Failure	20 (2.48%)
Fatigue	19 (2.36%)
Drug Interaction	17 (2.11%)
Gait Disturbance	15 (1.86%)
Tremor	15 (1.86%)
	Show More
Confusional State	11 (1.37%)
Dehydration	11 (1.37%)
Disorientation	11 (1.37%)
Therapeutic Agent Toxicity	11 (1.37%)
Bradycardia	10 (1.24%)
Drug Level Increased	9 (1.12%)
Drug Abuser	8 (.99%)
Dysarthria	8 (.99%)
Overdose	8 (.99%)
Restlessness	7 (.87%)
Dizziness	6 (.75%)
Headache	6 (.75%)
Nystagmus	6 (.75%)
Psychotic Disorder	6 (.75%)
Accidental Overdose	5 (.62%)
Agitation	5 (.62%)
Coma	5 (.62%)
Delirium	5 (.62%)
Electrocardiogram Qt Prolonged	5 (.62%)
Fall	5 (.62%)
Hypotension	5 (.62%)
Oedema Peripheral	5 (.62%)
Convulsion	4 (.5%)
Coordination Abnormal	4 (.5%)
Eyelid Oedema	4 (.5%)
Hypertension	4 (.5%)
Multiple Drug Overdose Intentional	4 (.5%)
Myoclonus	4 (.5%)
Poisoning	4 (.5%)
Sinus Bradycardia	4 (.5%)
Sluggishness	4 (.5%)
Speech Disorder	4 (.5%)
Tachycardia	4 (.5%)
Accommodation Disorder	3 (.37%)
Alanine Aminotransferase Increased	3 (.37%)
Apathy	3 (.37%)
Atrioventricular Block First Degree	3 (.37%)
Blood Creatine Phosphokinase Mb Inc...	3 (.37%)
Chills	3 (.37%)
Diplopia	3 (.37%)
Disturbance In Attention	3 (.37%)
Drug Exposure During Pregnancy	3 (.37%)
Drug Toxicity	3 (.37%)
Dry Mouth	3 (.37%)
Extrapyramidal Disorder	3 (.37%)
Gastrointestinal Sounds Abnormal	3 (.37%)
General Physical Health Deteriorati...	3 (.37%)
Haemodialysis	3 (.37%)
Hallucination	3 (.37%)
Hepatitis	3 (.37%)
Hypokinesia	3 (.37%)
Hypothyroidism	3 (.37%)
Ill-defined Disorder	3 (.37%)
Infection	3 (.37%)
Nephropathy Toxic	3 (.37%)
Sedation	3 (.37%)
Sopor	3 (.37%)
Subileus	3 (.37%)
Tooth Disorder	3 (.37%)
Urinary Retention	3 (.37%)
Abasia	2 (.25%)
Abdominal Pain	2 (.25%)
Abortion Incomplete	2 (.25%)
Acidosis	2 (.25%)
Anticonvulsant Drug Level Below The...	2 (.25%)
Antipsychotic Drug Level Above Ther...	2 (.25%)
Antipsychotic Drug Level Below Ther...	2 (.25%)
Antipsychotic Drug Level Increased	2 (.25%)
Arrhythmia	2 (.25%)
Aspartate Aminotransferase Increase...	2 (.25%)
Atrial Fibrillation	2 (.25%)
Autoimmune Thyroiditis	2 (.25%)
Bacterial Infection	2 (.25%)
Balance Disorder	2 (.25%)
Blood Creatine Phosphokinase Increa...	2 (.25%)
Blood Creatinine Increased	2 (.25%)
Blood Potassium Increased	2 (.25%)
Blood Thyroid Stimulating Hormone I...	2 (.25%)
Body Temperature Increased	2 (.25%)
Bradyphrenia	2 (.25%)
Cardiopulmonary Failure	2 (.25%)
Cerebellar Syndrome	2 (.25%)
Cognitive Disorder	2 (.25%)
Consciousness Fluctuating	2 (.25%)
Csf Oligoclonal Band Present	2 (.25%)
Death	2 (.25%)
Depressed Level Of Consciousness	2 (.25%)
Depression	2 (.25%)
Drug Administration Error	2 (.25%)
Dyspnoea	2 (.25%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Quilonum Retard, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Quilonum Retard is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Quilonum Retard

What are the most common Quilonum Retard adverse events reported to the FDA?

Neurological	94 (11.68%)
Suicidal And Self-injurious Behavio...	66 (8.2%)
Gastrointestinal Signs	57 (7.08%)
Medication Errors	57 (7.08%)
Movement Disorders	35 (4.35%)
Cardiac Arrhythmias	32 (3.98%)
Deliria	27 (3.35%)
Renal Disorders	24 (2.98%)
Chemical Injury And Poisoning	21 (2.61%)
Gastrointestinal Motility And Defec...	21 (2.61%)
Therapeutic And Nontherapeutic Effe...	18 (2.24%)
	Show More
Toxicology And Therapeutic Drug Mon...	18 (2.24%)
Electrolyte And Fluid Balance Condi...	14 (1.74%)
Lifestyle Issues	11 (1.37%)
Disturbances In Thinking	10 (1.24%)
Respiratory	10 (1.24%)
Infections - Pathogen Unspecified	9 (1.12%)
Cardiac And Vascular Investigations	8 (.99%)
Changes In Physical Activity	8 (.99%)
Epidermal And Dermal Conditions	8 (.99%)
Schizophrenia And Other Psychotic	8 (.99%)
Vision	8 (.99%)
Anxiety Disorders	7 (.87%)
Hepatobiliary	7 (.87%)
Mental Impairment	7 (.87%)
Urinary Tract Signs	7 (.87%)
Vascular Hypertensive	7 (.87%)
Headaches	6 (.75%)
Injuries	6 (.75%)
Neuromuscular	6 (.75%)
Thyroid Gland	6 (.75%)
Bacterial Infectious	5 (.62%)
Decreased And Nonspecific Blood Pre...	5 (.62%)
Enzyme	5 (.62%)
Neurological, Special Senses And Ps...	5 (.62%)
Renal And Urinary Tract Investigati...	5 (.62%)
Dental And Gingival Conditions	4 (.5%)
Hematological And Lymphoid Tissue T...	4 (.5%)
Hepatic And Hepatobiliary	4 (.5%)
Nephropathies	4 (.5%)
Ocular Infections, Irritations And ...	4 (.5%)
Physical Examination Topics	4 (.5%)
Seizures	4 (.5%)
Depressed Mood Disorders	3 (.37%)
Gastrointestinal Stenosis And Obstr...	3 (.37%)
Mood Disorders	3 (.37%)
Muscle	3 (.37%)
Salivary Gland Conditions	3 (.37%)
Sleep Disorders	3 (.37%)
Spinal Cord And Nerve Root	3 (.37%)
White Blood Cell	3 (.37%)
Abortions And Stillbirth	2 (.25%)
Acid-base	2 (.25%)
Bone, Calcium, Magnesium And Phosph...	2 (.25%)
Endocrine Investigations	2 (.25%)
Fatal Outcomes	2 (.25%)
Glaucoma And Ocular Hypertension	2 (.25%)
Heart Failures	2 (.25%)
Lower Respiratory Tract Disorders	2 (.25%)
Ocular Neuromuscular	2 (.25%)
Personality Disorders	2 (.25%)
Platelet	2 (.25%)
Psychiatric	2 (.25%)
Skin Appendage Conditions	2 (.25%)
Water, Electrolyte And Mineral	2 (.25%)
Anemias Nonhemolytic And Marrow Dep...	1 (.12%)
Appetite And General Nutritional	1 (.12%)
Chromosomal Abnormalities And Abnor...	1 (.12%)
Cornification And Dystrophic Skin	1 (.12%)
Eye	1 (.12%)
Gastrointestinal	1 (.12%)
Hematology Investigations	1 (.12%)
Lipid Metabolism	1 (.12%)
Metabolic, Nutritional And Blood Ga...	1 (.12%)
Musculoskeletal And Connective Tiss...	1 (.12%)
Ocular Sensory Symptoms	1 (.12%)
Peripheral Neuropathies	1 (.12%)
Pleural	1 (.12%)
Pulmonary Vascular	1 (.12%)
Red Blood Cell	1 (.12%)
Reproductive Organ And Breast Inves...	1 (.12%)
Sexual Function And Fertility	1 (.12%)
Skin And Subcutaneous Tissue	1 (.12%)
Tissue	1 (.12%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Quilonum Retard, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Quilonum Retard is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.